Pharmacovigilance teams face increasing pressure to detect and report safety signals quickly and accurately. While quantitative methods like disproportionality analysis help flag potential signals, regulatory expectations now demand a thorough…
Pharmacovigilance teams face increasing pressure to detect and report safety signals quickly and accurately. While quantitative methods like disproportionality analysis…
Pharmacovigilance teams face increasing pressure to detect and report safety signals quickly and accurately. While quantitative methods like disproportionality analysis…
In a world where appearance is currency and skincare routines are sacred, the cosmetic industry stands as a multi-billion-dollar titan.…
In today’s high-stakes pharmaceutical environment, patient safety is no longer merely a regulatory checkbox—it is the cornerstone of public trust,…
The Modernization of Cosmetics Regulation Act (MoCRA) 2022 has introduced significant changes to US cosmetics regulations. This new law modernizes…
As the cosmetics industry faces increasing regulatory scrutiny under the Modernization of Cosmetics Regulation Act (MoCRA), brands must adapt quickly…
With Artificial Intelligence (AI) in general, and Generative AI in particular becoming the next big thing in technology, we see…
Narasimha Kumar, Chief Product Officer at Datafoundry, delivered an engaging presentation titled “AI in Drug […]
In the world of safety vigilance, the meticulous task of literature surveillance is crucial for ensuring patient safety and health…